Patents by Inventor Peter Wayne Marks

Peter Wayne Marks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuroendocrine Tumor Treatment
    Publication number: 20170128425
    Abstract: A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Inventors: Peter Wayne Marks, David Lebwohl
  • Neuroendocrine Tumor Treatment
    Publication number: 20150148294
    Abstract: A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
    Type: Application
    Filed: January 29, 2015
    Publication date: May 28, 2015
    Applicant: Novartis AG
    Inventors: Peter Wayne Marks, David Lebwohl
  • Neuroendocrine tumor treatment
    Patent number: 9006224
    Abstract: A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: April 14, 2015
    Assignee: Novartis AG
    Inventors: Peter Wayne Marks, David Lebwohl
  • METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS
    Publication number: 20110294861
    Abstract: The present invention relates to the use of Compound I of the following formula in the treatment of iron overload resulting from hereditary hemochromatosis in patient in need of such a treatment and to a commercial package comprising Compound I together with instructions for the treatment of iron overload in hereditary hemochromatosis patients.
    Type: Application
    Filed: August 8, 2011
    Publication date: December 1, 2011
    Applicant: NOVARTIS AG
    Inventors: Hanspeter Nick, Lisa Rojkjaer, Janet Ellen Bodner, Peter Wayne Marks
  • METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS
    Publication number: 20110105575
    Abstract: The present invention relates to the use of Compound I of the following formula in the treatment of iron overload resulting from hereditary hemochromatosis in patient in need of such a treatment and to a commercial package comprising Compound I together with instructions for the treatment of iron overload in hereditary hemochromatosis patients.
    Type: Application
    Filed: May 21, 2007
    Publication date: May 5, 2011
    Inventors: Hanspeter Nick, Lisa Rojkjaer, Janet Ellen Bodner, Peter Wayne Marks
  • Neuroendocrine Tumor Treatment
    Publication number: 20080255029
    Abstract: A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
    Type: Application
    Filed: November 20, 2006
    Publication date: October 16, 2008
    Applicant: NOVARTIS AG
    Inventors: Peter Wayne Marks, David Lebwohl